Hudson Bay Capital Management LP Amicus Therapeutics, Inc. Transaction History

Hudson Bay Capital Management LP

$24.1 Billion
Q4 2024

A detailed history of Hudson Bay Capital Management LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 1,804,800 shares of FOLD stock, worth $15.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,804,800

Previous 1,425,000 26.65%

Holding current value

$15.2 Million

Previous $15.2 Million 11.71%

% of portfolio

0.07%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	BUY	$9.36 - $12.01 $3.55 Million - $4.56 Million	379,800 Added 26.65%	1,804,800 $17 Million
Q3 2024 Nov 13, 2024	BUY	$9.55 - $12.09 $3.41 Million - $4.32 Million	357,500 Added 33.49%	1,425,000 $15.2 Million
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $2.4 Million - $3.11 Million	265,000 Added 33.02%	1,067,500 $10.6 Million
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $5.06 Million - $6.3 Million	442,500 Added 122.92%	802,500 $9.45 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $1.84 Million - $2.69 Million	185,000 Added 105.71%	360,000 $5.11 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $235,600 - $277,200	20,000 Added 12.9%	175,000 $2.13 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $321,600 - $399,000	30,000 Added 24.0%	155,000 $1.95 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $540,100 - $701,250	-55,000 Reduced 30.56%	125,000 $1.31 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $817,400 - $1.46 Million	131,204 Added 268.88%	180,000 $1.93 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $385,000 - $608,974	48,796 New	48,796 $462,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $2.46 Million - $3.11 Million	-250,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $568,100 - $769,600	-65,000 Reduced 20.63%	250,000 $2.39 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $2.74 Million - $3.38 Million	315,000 New	315,000 $3.04 Million
Q3 2020 Nov 12, 2020	SELL	$12.89 - $15.89 $514,311 - $634,011	-39,900 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$8.86 - $15.69 $576,786 - $1.02 Million	-65,100 Reduced 62.0%	39,900 $601,000
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $298,350 - $502,200	-45,000 Reduced 30.0%	105,000 $970,000
Q4 2019 Feb 12, 2020	BUY	$7.48 - $10.75 $287,232 - $412,800	38,400 Added 34.41%	150,000 $1.46 Million
Q3 2019 Nov 13, 2019	BUY	$8.02 - $13.25 $574,232 - $948,700	71,600 Added 179.0%	111,600 $895,000
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $1.1 Million - $1.53 Million	-110,000 Reduced 73.33%	40,000 $544,000
Q4 2018 Feb 13, 2019	BUY	$8.38 - $13.44 $83,800 - $134,400	10,000 Added 7.14%	150,000 $1.44 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $464,000 - $661,600	40,000 Added 40.0%	140,000 $1.69 Million
Q2 2018 Aug 13, 2018	SELL	$13.13 - $17.09 $1.31 Million - $1.71 Million	-100,000 Reduced 50.0%	100,000 $1.56 Million
Q1 2018 May 14, 2018	BUY	$13.76 - $17.12 $1.38 Million - $1.71 Million	100,000 Added 100.0%	200,000 $3.01 Million
Q3 2017 Nov 13, 2017	BUY	$11.74 - $15.78 $1.17 Million - $1.58 Million	100,000	100,000 $1.51 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

283M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.36B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Amicus Therapeutics, Inc. Transaction History